The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,740.00
Bid: 1,745.00
Ask: 1,746.00
Change: -34.50 (-1.94%)
Spread: 1.00 (0.057%)
Open: 1,776.50
High: 1,776.50
Low: 1,740.00
Prev. Close: 1,774.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Sunni Militants Extend Control Over Eastern Iraq

Fri, 13th Jun 2014 10:24

LONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
Petra Diamonds Ltd shares jumped to the top of the FTSE 250 index after saying it has recovered another exceptional 122.52 carat blue diamond at the Cullinan mine in South Africa. The diamond mining company with operations in Tanzania, Botswana and South Africa said the stone will require further analysis in order to assess its potential value, but once this is completed, the company will make a decision on its sale plan for the stone. It said that the diamond will therefore not be sold until after the end of the company's current financial year, which ends on June 30.
----------
Tullow Oil PLC said it has refinanced its USD330 million Norwegian exploration loan facility, increaing the facility to USD500 million and extending the loan availability to the end of 2017. The FTSE 100 oil and gas exploration company said the arrangement replaces a previous facility arranged by Spring Energy before it was acquired by Tullow Oil in January 2013. It was due to expire in December 2014.
----------
GlaxoSmithKline PLC said a late stage study of its drug eltrombopag for the treatment of chronic immune thrombocytopenia in paediatric patients had met its primary endpoint. Immune thrombocytopenia is a bleeding disorder where the blood does not clot properly. The drug, which its marketed as Promacta in the US and Revolade in Europe, showed a statistically significant improvement in platelet counts compared to a placebo.
----------
AstraZeneca PLC said late Thursday the US Food and Drug Administration's Analgesic Drug Products Advisory Committee has recommended the FDA not require cardiovascular outcomes trials for a class of drugs including AstraZeneca's movantix treatment. Movantix is a mu-opioid receptor antagonist for the treatment of opioid-induced constipation in patients with chronic non-cancer pain. Opioids assist with chronic pain relief by binding mu-receptors in the brain, but also bind nu-receptors in the bowel, which means patients taking opioids for chronic pain can develop opioid-induced constipation.
----------
UK women's clothing retailer Bonmarche Holdings PLC reported strong profit and sales growth in its most recent financial year, driven by market share gains, price increases and growth in its online business. In its maiden results as a listed company, the clothing retailer targeting women over 50 years old, reported a pretax profit of GBP11.2 million for the financial year ended March 29, up from GBP6.1 million a year earlier, as the company posted a 12% increase in revenues to GBP164.3 million from GBP146.8 million the prior year. Like-for-like sales also grew strongly, up more than 10%. The retailer declared its first dividend of 2.1 pence per share for the year.
----------
MARKETS
----------
UK stocks are lower as investors show concern over the deteriorating situation in Iraq, while housebuilders are underperforming after Bank of England Governor Mark Carney gave his clearest warning yet, late Thursday, that UK interest rates may rise sooner than previously guided.
----------
FTSE 100: down 1.1% at 6,770.87
FTSE 250: down 1.9% at 15,826.89
AIM ALL-SHARE: down 0.9% at 788.18
----------
Brent oil has risen by more than 4% over the past three days since the situation in Iraq started to deteriorate reaching a nine-month high of USD114.04 a barrel.
----------
GBP-USD: up at USD1.6962
EUR-USD: up at USD1.3565

GOLD: up at USD1,273.69 per ounce
OIL (Brent): up at USD112.82 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
Sunni militants have captured at least one town in eastern Iraq, broadening their domination over portions of the country as they press south toward the capital Baghdad, reports said. Their lightning advances have sparked international fears that Iraq is falling apart, making room for the emergence of a radical enclave. Fighters from the radical Islamic State in Iraq and the Levant (ISIL), backed by local insurgents, seized the town of Jalula, 125 kilometres north-east of Baghdad, Dubai-based broadcaster Al Arabiya said. However, local officials said Jalula was under the control of Peshmerga - military troops of Kurdistan - after government forces abandoned their outposts in the town.
----------
The US is not considering sending troops into Iraq to stop advances by Islamist militants, a State Department spokeswoman said. Describing the situation as "alarming" and saying there has been a "clear structural breakdown" in Iraq, spokeswoman Jen Psaki said the US and Iraq "share a commitment to addressing threats from groups such as ISIL." Psaki spoke at a briefing after US President Barack Obama said his administration was "looking at all options" on how to respond to the latest violence in Iraq.
----------
Bank of England governor Mark Carney signalled that interest rate could rise sooner than forecast, due to strong economic growth. In a speech at the annual Mansion House in the City of London to financial and political leaders on Thursday, the governor said that interest rate "could happen sooner than markets currently expect." "There's already great speculation about the exact timing of the first rate hike and this decision is becoming more balanced. However, the decision would be dependent on data and is not a pre-set course", he added. There remains more spare capacity in the economy that would need to be used up first, he said.
----------
Fitch Ratings affirmed the sovereign ratings of the UK with 'stable' outlook, citing its favourable macroeconomic trends. The long-term ratings were maintained at 'AA+'. Strong GDP growth, falling unemployment and inflation close to the 2% target continued in the economy since the last review in December 2013, Fitch said.
----------
UK APR CB LEADING INDEX UP 0.5% VS. 0.3% IN MARCH
----------
UK APRIL CONSTRUCTION OUTPUT UP 4.6% ON YEAR, UP 1.2% ON MONTH
----------
Eurozone employment grew for the second straight quarter in the first three months of the year, figures from Eurostat showed. The number of employed rose 0.1% from the fourth quarter of 2013, when there was a similar gain. In the third quarter of 2013, the reading was flat. Year-on-year, the number of employed increased 0.2% in the first quarter, after a 0.4% slump in the previous three months.
----------
The euro area trade surplus increased slightly in April as the decline in imports exceeded the fall in exports, data from Eurostat showed. The seasonally adjusted trade surplus rose to EUR15.8 billion from EUR15.4 billion in March. On an unadjusted basis, the trade surplus fell to EUR15.7 billion in April from EUR16.7 billion in March. It was forecast to fall to EUR16.3 billion.
----------
China's industrial production and retail sales growth accelerated in May, suggesting that measures adopted by the government to kick start the recovery finally started to bear fruit. Industrial production grew at a pace of 8.8% year-on-year in May, following April's 8.7% increase, figures from the National Bureau of Statistics showed. The rate came in line with economists' expectations. At the same time, retail sales advanced by a more-than-expected 12.5% annually in May, faster than the 11.9% rise seen a month ago. Sales were expected to rise by 12.1%.
----------
The Bank of Japan retained its monetary policy unchanged while raising its view on overseas growth. The policy board of the BoJ unanimously decided to increase the monetary base at an annual pace of about JPY60-JPY70 trillion as widely expected by economists. "Overseas economies -- mainly advanced economies -- are recovering, albeit with a lackluster performance still seen in part," the bank said. With regard to the Japan outlook, the bank said the economy is expected to continue a moderate recovery as a trend, while it will be affected by the subsequent decline in demand following the front-loaded increase prior to the consumption tax hike.
----------
Japan industrial production was revised to show a steeper decline in April, final figures from the Ministry of Economy, Trade and Industry showed. Industrial output declined 2.8% on month in April, a faster rate of decline than the preliminary estimate of a 2.5% fall. In March, production rose 0.7%. On a year-over-year basis, industrial output rose by a revised 3.8%, down from the preliminary estimate of a 4.1% rise. This follows the 6.4% increase in March.
----------
EU Energy Commissioner Guenther Oettinger says he expects gas talks between Russia and Moscow to resume on Saturday. "My hope is that we can continue tomorrow," he told journalists on the margins of an EU energy ministers' meeting in Luxembourg, adding that he expects Ukraine and Russia to be represented by their energy ministers and the chiefs of their respective gas companies. He said he is flexible on the location, whether it be "Brussels or Berlin or Kiev or Moscow."
----------
Ukraine said late Thursday that separatists in eastern Ukraine had obtained heavy armour from neighbouring Russia. Pro-Russian militants had brought at least three tanks across the border, Interior Minister Arsen Avakov told journalists in Kiev. President Petro Poroshenko had voiced "extreme concern" over the tanks and the wider clashes in eastern Ukraine, in a phone call, said European Commission President Jose Manuel Barroso, speaking at a press conference in Georgia. Moscow made no immediate comment.
----------
Neymar's two goals, some help from the Japanese referee, and big support from the local fans have given hosts Brazil the perfect start to the World Cup. The 3-1 victory over Croatia in the tournament opener Thursday sparked widespread celebrations in the country, and coach Luiz Felipe Scolari is relieved that his team can book a place in the last 16 as early as Tuesday if they beat Mexico, and other results go their way. "This victory gives us a chance to breathe and another victory gives me room to breathe," Scolari said, describing his players as excellent.
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.


More News
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.